Thermo Fisher Scientific is trading 4.1% up now at $584.84 as investors react to its July 23, 2026 beat and raise earnings report and upwardly revised full-year guidance.
- Management lifted its 2026 outlook based on recovering bioprocessing demand and significant innovation in AI-driven instrumentation.
- The stock is seeing additional support from a 1.80% rally in the XLV ETF, driven by institutional buying and broader AI optimism within the healthcare sector.